{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:51:14Z","timestamp":1790484674141,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R25GM082406"],"award-info":[{"award-number":["R25GM082406"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["U54MD007579"],"award-info":[{"award-number":["U54MD007579"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA253555"],"award-info":[{"award-number":["R21CA253555"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA163068"],"award-info":[{"award-number":["U54CA163068"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA163071"],"award-info":[{"award-number":["U54CA163071"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K12HD103083"],"award-info":[{"award-number":["1K12HD103083"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25MD007607"],"award-info":[{"award-number":["R25MD007607"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bbih.2022.100558","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T12:51:01Z","timestamp":1668689461000},"page":"100558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Alexandra N.","family":"Aquino-Acevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Knochenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesenia","family":"Castillo-Ocampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ortiz-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadiel A.","family":"Rivera-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camily","family":"Morales-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie E.","family":"Cruz-Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvin R.","family":"Hern\u00e1ndez-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shonagh","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Bonilla-Claudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung-Tsa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dutil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Previs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9081-5339","authenticated-orcid":false,"given":"Guillermo N.","family":"Armaiz-Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbih.2022.100558_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10020032","article-title":"Tackling cancer resistance by immunotherapy: updated clinical impact and safety of PD-1\/PD-L1 inhibitors","volume":"10","author":"Abdin","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbih.2022.100558_bib2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/90.1.30","article-title":"Stress and immune responses after surgical treatment for regional breast cancer","volume":"90","author":"Andersen","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"Suppl","key":"10.1016\/j.bbih.2022.100558_bib4","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.bbi.2012.06.005","article-title":"Neuroendocrine influences on cancer progression","volume":"30","author":"Armaiz-Pena","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2022.100558_bib5","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.18632\/oncotarget.2887","article-title":"Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth","volume":"6","author":"Armaiz-Pena","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbih.2022.100558_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1470-2045(21)00303-X","article-title":"Immunotherapy in ovarian cancer: we are not there yet","volume":"22","author":"Barber","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jpsychores.2009.05.016","article-title":"Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: an exploratory study","volume":"67","author":"Blomberg","year":"2009","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.bbih.2022.100558_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.2016.172","article-title":"CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer","volume":"115","author":"Bronger","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbih.2022.100558_bib9","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.2147\/CMAR.S179189","article-title":"IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis","volume":"10","author":"Browning","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.bbih.2022.100558_bib57","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3802\/jgo.2015.26.4.336","article-title":"Role of aggressive surgical cytoreduction in advanced ovarian cancer","volume":"26","author":"Chang","year":"2015","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc3978","article-title":"Sympathetic nervous system regulation of the tumour microenvironment","volume":"15","author":"Cole","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbih.2022.100558_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01077","article-title":"Neuroendocrine regulation of tumor-associated immune cells","volume":"9","author":"Colon-Echevarria","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092671","article-title":"Zoledronic acid abrogates restraint stress-induced macrophage infiltration, PDGF-AA expression, and ovarian cancer growth","volume":"12","author":"Colon-Echevarria","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbih.2022.100558_bib13","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3389\/fonc.2020.01492","article-title":"Chronic stress promotes cancer development","volume":"10","author":"Dai","year":"2020","journal-title":"Front. Oncol."},{"issue":"482","key":"10.1016\/j.bbih.2022.100558_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2018.03.019","article-title":"Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients","volume":"Jul","author":"Dalal","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbih.2022.100558_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.31557\/APJCP.2021.22.2.315","article-title":"Cytokines as prognostic biomarkers of epithelial ovarian cancer (EOC): a systematic review and meta-analysis","volume":"22","author":"Fahmi","year":"2021","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.bbih.2022.100558_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1158\/2159-8290.CD-18-1398","article-title":"Tumor neurobiology and the war of nerves in cancer","volume":"9","author":"Faulkner","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbih.2022.100558_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbih.2022.100558_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/10253890802137437","article-title":"Chronic restraint stress impairs T-cell immunity and promotes tumor progression in mice","volume":"12","author":"Frick","year":"2009","journal-title":"Stress"},{"key":"10.1016\/j.bbih.2022.100558_bib18","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.4049\/jimmunol.180.12.7958","article-title":"IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T lymphocytes","volume":"180","author":"Gagnon","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbih.2022.100558_bib19","first-page":"2875","article-title":"Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity","volume":"29","author":"Giuntoli","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbih.2022.100558_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194705","article-title":"Current possibilities of gynecologic cancer treatment with the use of immune checkpoint inhibitors","volume":"20","author":"Grywalska","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbih.2022.100558_bib21","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbih.2022.100558_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12964-020-00589-8","article-title":"CCL2\/CCR2 signaling in cancer pathogenesis","volume":"18","author":"Hao","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbih.2022.100558_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41416-019-0725-x","article-title":"Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment","volume":"122","author":"Horikawa","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbih.2022.100558_bib24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4149\/neo_2013_071","article-title":"Clinical significance of ascites in epithelial ovarian cancer","volume":"60","author":"Huang","year":"2013","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbih.2022.100558_bib25","first-page":"6457","article-title":"Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma","volume":"15","author":"Imai","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbih.2022.100558_bib26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2015.05.009","article-title":"Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-alpha and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer","volume":"138","author":"Kolomeyevskaya","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib27","doi-asserted-by":"crossref","first-page":"10389","DOI":"10.1158\/0008-5472.CAN-07-0858","article-title":"Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer","volume":"67","author":"Landen","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbih.2022.100558_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.bbih.2022.100558_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10634","article-title":"Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination","volume":"7","author":"Le","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbih.2022.100558_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.physbeh.2006.08.025","article-title":"Measuring cortisol in human psychobiological studies","volume":"90","author":"Levine","year":"2007","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.bbih.2022.100558_bib59","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1002\/mco2.147","article-title":"Role of chemokine systems in cancer and inflammatory diseases","volume":"3","author":"Li","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bbih.2022.100558_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.592415","article-title":"Monocyte chemoattractant protein 1 promotes VEGF-A expression in OSCC by activating ILK and MEK1\/2 signaling and downregulating miR-29c","volume":"10","author":"Lien","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib32","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","article-title":"Cytokine patterns in patients with cancer: a systematic review","volume":"14","author":"Lippitz","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1037\/a0035730","article-title":"Biobehavioral approaches to cancer progression and survival: mechanisms and interventions","volume":"70","author":"Lutgendorf","year":"2015","journal-title":"Am. Psychol."},{"key":"10.1016\/j.bbih.2022.100558_bib34","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbi.2007.12.012","article-title":"Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients","volume":"22","author":"Lutgendorf","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2022.100558_bib35","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1200\/JCO.2005.10.015","article-title":"Social support, psychological distress, and natural killer cell activity in ovarian cancer","volume":"23","author":"Lutgendorf","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01073","article-title":"The controversial role of PD-1 and its ligands in gynecological malignancies","volume":"9","author":"Marinelli","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib37","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/mi.2016.135","article-title":"Regulation of IL-12p40 by HIF controls Th1\/Th17 responses to prevent mucosal inflammation","volume":"10","author":"Marks","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bbih.2022.100558_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10080244","article-title":"Ovarian cancer immunotherapy: preclinical models and emerging therapeutics","volume":"10","author":"McCloskey","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbih.2022.100558_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13048-016-0236-9","article-title":"Adoptive immunotherapy against ovarian cancer","volume":"9","author":"Mittica","year":"2016","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.bbih.2022.100558_bib40","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S1470-2045(21)00342-9","article-title":"Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial","volume":"22","author":"Monk","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib41","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1200\/JCO.21.00306","article-title":"Atezolizumab, bevacizumab, and chemotherapy for newly diagnosed stage III or IV ovarian cancer: placebo-controlled randomized phase III trial (IMagyn050\/GOG 3015\/ENGOT-OV39)","volume":"39","author":"Moore","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbih.2022.100558_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.copsyc.2015.03.007","article-title":"Current directions in stress and human immune function","volume":"5","author":"Morey","year":"2015","journal-title":"Curr. Opin. Psychol."},{"key":"10.1016\/j.bbih.2022.100558_bib43","doi-asserted-by":"crossref","first-page":"29919","DOI":"10.1074\/jbc.M611539200","article-title":"Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism","volume":"282","author":"Nilsson","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbih.2022.100558_bib44","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1158\/0008-5472.CAN-05-0623","article-title":"Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine","volume":"65","author":"Nilsson","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbih.2022.100558_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1258\/000456304322664663","article-title":"Measurement of catecholamines and their metabolites","volume":"41","author":"Peaston","year":"2004","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbih.2022.100558_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159059","article-title":"Induction of suppressor cells and increased tumor growth following chronic psychosocial stress in male mice","volume":"11","author":"Schmidt","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbih.2022.100558_bib47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1037\/0033-2909.130.4.601","article-title":"Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry","volume":"130","author":"Segerstrom","year":"2004","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.bbih.2022.100558_bib48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1158\/2159-8290.CD-20-1680","article-title":"The next decade of immune checkpoint therapy","volume":"11","author":"Sharma","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbih.2022.100558_bib58","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12885-019-5558-8","article-title":"Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers","volume":"19","author":"Sidorkiewicz","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbih.2022.100558_bib49","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.bbih.2022.100558_bib50","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbih.2022.100558_bib51","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"Thaker","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbih.2022.100558_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbi.2006.06.007","article-title":"Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments","volume":"21","author":"Thornton","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2022.100558_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058488","article-title":"Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10","volume":"8","author":"Voorhees","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbih.2022.100558_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.577869","article-title":"Immunotherapy for ovarian cancer: adjuvant, combination, and neoadjuvant","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbih.2022.100558_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cac2.12010","article-title":"CXCL5\/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target","volume":"40","author":"Zhang","year":"2020","journal-title":"Cancer Commun. (Lond)"}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266635462200148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266635462200148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:34:52Z","timestamp":1762986892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266635462200148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":59,"alternative-id":["S266635462200148X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2022.100558","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2022.100558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100558"}}